FBIO Return on Tangible Equity | Fortress Biotech, Inc.

Fortress Biotech, Inc. (FBIO) Return on Tangible Equity

2026-06-30: Return Tang Equity 93.19%.
2026-03-31: Return Tang Equity 109.13%.
2025-12-31: Return Tang Equity 188.10%.
2025-09-30: Return Tang Equity 46.65%.

Complete source-backed return tang equity history.

Available history: 2007-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	93.19%
2026-03-31	109.13%
2025-12-31	188.10%
2025-09-30	46.65%
2025-06-30	330.64%
2025-03-31	151.38%
2024-12-31	165.63%
2024-09-30	316.42%
2024-06-30	209.46%
2024-03-31	361.21%
2023-12-31	370.01%
2023-09-30	339.38%
2023-06-30	434.30%
2023-03-31	1323.66%
2022-12-31	2100.83%
2022-09-30	-624.52%
2022-06-30	-307.03%
2022-03-31	-146.93%
2021-12-31	-83.51%
2021-09-30	-63.04%
2021-06-30	-43.72%
2021-03-31	-59.02%
2020-12-31	-69.38%
2020-09-30	-84.13%
2020-06-30	-153.39%
2020-03-31	-464.68%
2019-12-31	-20704.66%
2019-09-30	8493.63%
2019-06-30	-434.20%
2019-03-31	-6242.37%
2018-12-31	462.09%
2018-09-30	-1341.81%
2018-06-30	-686.64%
2018-03-31	-882.08%
2017-12-31	-202.38%
2017-09-30	-3190.59%
2017-06-30	-161.11%
2017-03-31	-456.35%
2016-12-31	-2256.14%
2016-09-30	-372.65%
2016-06-30	-162.57%
2016-03-31	-112.67%
2015-12-31	-87.11%
2015-09-30	-76.59%
2015-06-30	-48.57%
2015-03-31	-42.54%
2014-12-31	-28.91%
2014-09-30	-38.22%
2014-06-30	-41.06%
2014-03-31	-47.25%
2013-12-31	-45.72%
2013-09-30	-41.16%
2013-06-30	-70.28%
2013-03-31	-111.92%
2012-12-31	-125.32%
2012-09-30	-88.11%
2012-06-30	-68.29%
2012-03-31	-151.47%
2011-12-31	-190.05%
2011-09-30	70.04%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	188.10%
2024-12-31	165.63%
2023-12-31	370.01%
2022-12-31	2100.83%
2021-12-31	-83.51%
2020-12-31	-69.38%
2019-12-31	-20704.66%
2018-12-31	462.09%
2017-12-31	-202.38%
2016-12-31	-2256.14%
2015-12-31	-87.11%
2014-12-31	-28.91%
2013-12-31	-45.72%
2012-12-31	-125.31%
2011-12-31	-190.05%
2010-12-31	62.79%
2009-12-31	23.06%
2008-12-31	-75980.00%
2007-12-31	96.18%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ALX ONCOLOGY HOLDINGS INC (ALXO)	United States	$0.187B	-3.52
PepGen Inc. (PEPG)	United States	$0.186B	-1.73
AN2 Therapeutics, Inc. (ANTX)	United States	$0.185B	-4.84
Organogenesis Holdings Inc. (ORGO)	United States	$0.182B	-3.70
Zentalis Pharmaceuticals, Inc. (ZNTL)	United States	$0.196B	-2.48
ORAMED PHARMACEUTICALS INC. (ORMP)		$0.199B	1.13
Nkarta, Inc. (NKTX)	United States	$0.205B	-1.73
Tonix Pharmaceuticals Holding Corp. (TNXP)	United States	$0.166B	-1.34
Minerva Neurosciences, Inc. (NERV)	United States	$0.165B	-0.66
ADC Therapeutics SA (ADCT)		$0.163B	-1.39